RH has previously mentioned that PYC intended to provide the opportunity to access ongoing treatment for those who had participated in the SAD program as a matter of mutual obligation.
This latest approval supports the collection of data which no doubt PYC would consider valuable in terms of being clinically recognized, because maybe PYC think it works pretty darn good., and maybe the patients also share that optimism, which would probably underscore their reasoning to continue treatment.
- Forums
- ASX - By Stock
- PYC
- Ann: Extension of RP11 Single Dose Study Into Multiple Dose Study
Ann: Extension of RP11 Single Dose Study Into Multiple Dose Study, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
10.8¢ |
Change
0.003(2.38%) |
Mkt cap ! $501.6M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $300.7K | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 900649 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 305686 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 896788 | 0.105 |
24 | 1888322 | 0.100 |
1 | 5100 | 0.098 |
3 | 79605 | 0.095 |
2 | 187912 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 227374 | 11 |
0.115 | 877319 | 10 |
0.120 | 175000 | 1 |
0.125 | 709274 | 8 |
0.130 | 1974341 | 10 |
Last trade - 14.05pm 23/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online